Latest News

Clinical Trials in Osteosarcoma

Clinical Trials in Osteosarcoma

1. Therapeutic trials

Newly Diagnosed Osteosarcoma

Phase III

  • A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy. Read More >

Phase II

  • Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma. Read More >
  • Neoadjuvant and Adjuvant Pamidronate With Induction and Maintenance Chemotherapy in Treating Patients With Osteosarcoma. Read More >
  • Bone Cancer: Treatment Outcome Based on Tumor Response. Read More >

Relapsed Osteosarcoma (Lung)

Phase II

  • Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma. Read More >

Phase Ib/IIa

  • Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung. Read More >

Recurrent, refractory Osteosarcoma

Phase II

  • Samarium Sm 153 Lexidronam Pentasodium and Autologous Stem Cell Transplant Followed By Radiation Therapy in Treating Patients With Recurrent or Refractory, Metastatic, or Unresectable Osteosarcoma. Read More >

Phase I

  • Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma. Read More >

2. Non-Therapeutic trials

  • Osteosarcoma Biology Protocol: Companion to Children's Oncology Group Therapeutic studies. Read More >
  • Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma. Read More >

Osteosarcoma Online > Health Professionals > Clinical Trials in Osteosarcoma

Site Design: Caroline Courtney